Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cholesterol Biosynthesis Pathway WP197,7.639709684831186e-07,16.10091743119266,226.7771721468901,"['IDI1', 'SQLE', 'NSDHL', 'HMGCS1', 'CYP51A1', 'SC5D', 'MSMO1', 'HMGCR', 'FDFT1']",0.0003323273712901566,0,0,9
2,"GPCRs, Class A Rhodopsin-like WP455",2.3277239970753257e-06,5.074042758787293,65.81347842325707,"['GPR27', 'GPR12', 'P2RY14', 'CHRM5', 'F2R', 'GPR85', 'OPRK1', 'ADRA1D', 'NMBR', 'HTR4', 'HTR5A', 'MCHR1', 'HCRTR2', 'HRH1', 'HTR7', 'MC1R']",0.0005062799693638833,0,0,16
3,Cytoplasmic Ribosomal Proteins WP477,9.932970906764959e-05,3.057488048941697,28.18106867255954,"['RPL3', 'RPS7', 'RPLP0', 'RPSA', 'RPL23A', 'RPL10A', 'RPS4Y1', 'RPS26', 'RPS25', 'RPS15A', 'RPS27', 'RPL18A', 'RPLP2', 'RPL15', 'RPL18', 'RPL17', 'RPS13', 'RPL19', 'RPS23']",0.01440280781480919,0,0,19
4,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.0010630262852470184,3.8294460641399417,26.218821186209507,"['BEX3', 'CDKN1B', 'HSPA5', 'RIPK2', 'F2R', 'HSPB1', 'PTK2B', 'APOE', 'VIM', 'ETS1']",0.10508224915068003,0,0,10
5,Vitamin D Receptor Pathway WP2877,0.0014634773443506187,2.9695115311744593,19.381823392573178,"['ABCB1', 'TGFB1', 'CDKN1B', 'IGFBP5', 'GADD45A', 'CDKN2A', 'IGFBP3', 'PTHLH', 'ADAMTS5', 'SFRP1', 'PNOC', 'TIMP2', 'TIMP3']",0.10508224915068003,0,0,13
6,Monoamine GPCRs WP58,0.0021387513237029116,5.8342572062084255,35.86628936984802,"['HRH1', 'HTR7', 'CHRM5', 'ADRA1D', 'HTR4', 'HTR5A']",0.10508224915068003,0,0,6
7,Nanomaterial induced apoptosis WP2507,0.002194353690941533,7.6352429296591735,46.74194723958723,"['ENDOG', 'CASP6', 'HTRA2', 'BAX', 'CYCS']",0.10508224915068003,0,0,5
8,Statin inhibition of cholesterol production WP430,0.002194353690941533,7.6352429296591735,46.74194723958723,"['SQLE', 'HMGCR', 'APOE', 'LDLR', 'FDFT1']",0.10508224915068003,0,0,5
9,ACE Inhibitor Pathway WP554,0.0023652752345993643,32.02127659574468,193.62820495197963,"['TGFB1', 'ATP6AP2', 'AGT']",0.10508224915068003,0,0,3
10,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.00241568388852138,3.3494897959183674,20.183264667948958,"['IDI1', 'SQLE', 'NSDHL', 'HMGCS1', 'CYP51A1', 'ACOT2', 'SC5D', 'MSMO1', 'HMGCR', 'FDFT1']",0.10508224915068003,0,0,10
11,Allograft Rejection WP2328,0.0031745620572366496,4.406259350128658,25.347384047230243,"['ABCB1', 'TGFB1', 'HLA-B', 'HLA-C', 'HLA-A', 'VIM', 'HLA-F']",0.1255394995361766,0,0,7
12,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.004794656511026457,8.544421906693712,45.62937649802614,"['SFRP1', 'SST', 'SMAD9', 'DCN']",0.14005628856825636,0,0,4
13,Imatinib and Chronic Myeloid Leukemia WP3640,0.004796918881073275,5.937394247038917,31.704387762317275,"['SPRED2', 'ABCB1', 'CDKN1B', 'GADD45A', 'PIM1']",0.14005628856825636,0,0,5
14,Peptide GPCRs WP24,0.004796918881073275,5.937394247038917,31.704387762317275,"['MC1R', 'OPRK1', 'NMBR', 'ACKR1', 'HCRTR2']",0.14005628856825636,0,0,5
15,NRF2 pathway WP2884,0.0048295271920088395,2.4232548915917502,12.923234587115049,"['HSP90AA1', 'TGFB1', 'SRXN1', 'SLC2A12', 'SLC39A11', 'SLC39A13', 'SLC7A11', 'SLC5A3', 'CES4A', 'DNAJB1', 'SLC39A6', 'SLC39A7', 'SLC39A3', 'CBR3']",0.14005628856825636,0,0,14
16,Composition of Lipid Particles WP3601,0.007370669601247071,inf,inf,"['APOE', 'LDLR']",0.16874954087065663,0,0,2
17,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.007370669601247071,inf,inf,"['TGFB1', 'VIP']",0.16874954087065663,0,0,2
18,COVID-19 adverse outcome pathway WP4891,0.007370669601247071,inf,inf,"['IL7', 'AGT']",0.16874954087065663,0,0,2
19,Gastric acid production WP2596,0.007370669601247071,inf,inf,"['CCK', 'VIP']",0.16874954087065663,0,0,2
20,Photodynamic therapy-induced unfolded protein response WP3613,0.00889489461870424,4.009146341463414,18.93230278603255,"['XBP1', 'HSPA5', 'DDIT3', 'DNAJB9', 'CALR', 'BBC3']",0.1876232298390907,0,0,6
21,Zinc homeostasis WP3529,0.009057673164645758,4.856945085371481,22.847764307335495,"['SLC39A6', 'SLC39A11', 'SLC39A13', 'SLC39A7', 'SLC39A3']",0.1876232298390907,0,0,5
22,Biogenic Amine Synthesis WP550,0.01036544261818704,10.671732522796352,48.762110833201525,"['GAD1', 'PAH', 'GAD2']",0.2049530699505165,0,0,3
23,TP53 network WP1742,0.010924292947127089,6.1019994204578385,27.56130509411026,"['CDKN2A', 'GADD45A', 'BAX', 'BBC3']",0.20661162747827322,0,0,4
24,Selenium Micronutrient Network WP15,0.0117523320113842,2.951611770489501,13.116087817948486,"['RFK', 'PNPO', 'PLAT', 'SELENOT', 'KMO', 'SEPHS2', 'LDLR', 'SELENOH']",0.21301101770633862,0,0,8
25,Senescence and Autophagy in Cancer WP615,0.013711306294621793,2.255731352922183,9.67603748257083,"['CEBPB', 'TGFB1', 'CDKN1B', 'IGFBP5', 'CDKN2A', 'IGFBP3', 'FN1', 'PLAT', 'IGFBP7', 'IL6ST', 'CXCL14', 'SLC39A3']",0.23857672952641917,0,0,12
26,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.015289273545795552,5.338742393509127,22.319166587454653,"['TGFB1', 'FN1', 'VIM', 'RUNX2']",0.2558013074008102,0,0,4
27,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.016990256007562234,8.00303951367781,32.61330857085663,"['NSDHL', 'CYP51A1', 'SC5D']",0.2639557629746276,0,0,3
28,Mevalonate pathway WP3963,0.016990256007562234,8.00303951367781,32.61330857085663,"['HMGCS1', 'HMGCR', 'ACAT2']",0.2639557629746276,0,0,3
29,Development of ureteric collection system WP5053,0.020449994908624126,3.2060975609756097,12.47099059136021,"['SALL1', 'FRAS1', 'ETV4', 'GLI3', 'FGFR2', 'FREM2']",0.3022996203150588,0,0,6
30,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.020848249676900608,21.32591093117409,82.54162439738828,"['BAX', 'IL6ST']",0.3022996203150588,0,0,2
31,Endochondral Ossification with Skeletal Dysplasias WP4808,0.02459398007444712,2.516353180783515,9.323726627645629,"['ADAMTS5', 'TGFB1', 'HMGCS1', 'TIMP3', 'PLAT', 'GLI3', 'RUNX2', 'PTHLH']",0.33432441663701556,0,0,8
32,Endochondral Ossification WP474,0.02459398007444712,2.516353180783515,9.323726627645629,"['ADAMTS5', 'TGFB1', 'HMGCS1', 'TIMP3', 'PLAT', 'GLI3', 'RUNX2', 'PTHLH']",0.33432441663701556,0,0,8
33,Nuclear Receptors Meta-Pathway WP2882,0.026902566789140624,1.6401515151515151,5.930022874817369,"['HSP90AA1', 'ABCB1', 'CDKN1B', 'TGFB1', 'SRXN1', 'SLC2A12', 'SLC39A11', 'AIP', 'SLC39A13', 'SLC7A11', 'SLC5A3', 'CES4A', 'TGFBR3', 'DNAJB1', 'RGS2', 'B3GNT5', 'SLC39A6', 'BAX', 'SLC39A7', 'CBR3', 'SLC39A3', 'FKBP5']",0.35462474403867184,0,0,22
34,Aryl Hydrocarbon Receptor Pathway WP2873,0.03556075273917722,3.140937593311436,10.479778171301234,"['HSP90AA1', 'CDKN1B', 'TGFB1', 'AIP', 'BAX']",0.4475525172377996,0,0,5
35,IL-18 signaling pathway WP4754,0.03600997265131721,1.6251171508903468,5.401823366092597,"['CEBPB', 'STOML1', 'CD81', 'RGS16', 'PRKCD', 'COX17', 'FN1', 'HSPB1', 'BPGM', 'PLD1', 'RUNX2', 'ADAMTS5', 'ARL4D', 'SYT10', 'TIMP3', 'CYCS', 'BAX', 'CD36', 'ITM2C', 'ARF6']",0.4475525172377996,0,0,20
36,Cytokines and Inflammatory Response WP530,0.03933127237099307,10.661943319838057,34.49922681338798,"['TGFB1', 'IL7']",0.45023956529952597,0,0,2
37,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.03933127237099307,10.661943319838057,34.49922681338798,"['FN1', 'VIM']",0.45023956529952597,0,0,2
38,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.03933127237099307,10.661943319838057,34.49922681338798,"['APOE', 'LDLR']",0.45023956529952597,0,0,2
39,Apoptosis Modulation and Signaling WP1772,0.043269904106455016,2.092142002393299,6.569949222216987,"['HRK', 'ENDOG', 'CASP6', 'CDKN2A', 'HTRA2', 'CYCS', 'BAX', 'PTPN13', 'BBC3']",0.48262585349507514,0,0,9
40,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.0479605925928256,4.571862787668259,13.88646444543655,"['IDI1', 'HMGCS1', 'HMGCR']",0.5215714444469783,0,0,3
41,Nephrotic syndrome WP4758,0.05202648425825802,2.4648217636022514,7.286018993069532,"['MYO1E', 'ANLN', 'TRPC6', 'INF2', 'GPC5', 'WDR73']",0.5519883085937131,0,0,6
42,Oncostatin M Signaling Pathway WP2374,0.06139912721867399,2.03549607215595,5.679766125002352,"['CEBPB', 'CDKN1B', 'PRKCH', 'PRKCD', 'TIMP3', 'PTK2B', 'IL6ST', 'LDLR']",0.5980005307984407,0,0,8
43,Dopaminergic Neurogenesis WP2855,0.06186212387570077,7.107287449392713,19.778494826947547,"['TGFB1', 'ASCL1']",0.5980005307984407,0,0,2
44,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.06186212387570077,7.107287449392713,19.778494826947547,"['CEBPB', 'ALDH1L1']",0.5980005307984407,0,0,2
45,NAD Biosynthesis II (from tryptophan) WP2485,0.06186212387570077,7.107287449392713,19.778494826947547,"['NMNAT1', 'KMO']",0.5980005307984407,0,0,2
46,Unfolded protein response WP4925,0.07422385221991196,2.8454361054766735,7.400039525330871,"['XBP1', 'HSPA5', 'DDIT3', 'BBC3']",0.6459417943792497,0,0,4
47,miRNA targets in ECM and membrane receptors WP2911,0.07736922135651805,3.5552178318135765,9.098393430991273,"['COL5A3', 'COL5A2', 'FN1']",0.6459417943792497,0,0,3
48,Phytochemical activity on NRF2 transcriptional activation WP3,0.07736922135651805,3.5552178318135765,9.098393430991273,"['AIMP2', 'CEBPB', 'SLC7A11']",0.6459417943792497,0,0,3
49,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.07736922135651805,3.5552178318135765,9.098393430991273,"['TGFB1', 'FN1', 'IGFBP7']",0.6459417943792497,0,0,3
50,Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs) WP688,0.08589251741219775,inf,inf,['FMO5'],0.6459417943792497,0,0,1
51,Codeine and Morphine Metabolism WP1604,0.08589251741219775,inf,inf,['ABCB1'],0.6459417943792497,0,0,1
52,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.08589251741219775,inf,inf,['AGT'],0.6459417943792497,0,0,1
53,Cardiac Progenitor Differentiation WP2406,0.0867460985592155,2.667342799188641,6.521039213853353,"['TGFB1', 'TNNT2', 'ROR2', 'THY1']",0.6459417943792497,0,0,4
54,Folate Metabolism WP176,0.0867460985592155,2.667342799188641,6.521039213853353,"['AHCY', 'RFK', 'PLAT', 'LDLR']",0.6459417943792497,0,0,4
55,Genes controlling nephrogenesis WP4823,0.0867460985592155,2.667342799188641,6.521039213853353,"['CD36', 'ETV4', 'GLI3', 'FGFR2']",0.6459417943792497,0,0,4
56,"GPCRs, Other WP117",0.08707092788537477,2.320238357978371,5.663776611770276,"['HTR7', 'ADGRV1', 'F2R', 'ADRA1D', 'ACKR1']",0.6459417943792497,0,0,5
57,IL1 and megakaryocytes in obesity WP2865,0.08761049624913962,5.32995951417004,12.977675737453291,"['F2R', 'TIMP2']",0.6459417943792497,0,0,2
58,Sulfation Biotransformation Reaction WP692,0.08761049624913962,5.32995951417004,12.977675737453291,"['SULT4A1', 'PAPSS2']",0.6459417943792497,0,0,2
59,Transcriptional cascade regulating adipogenesis WP4211,0.08761049624913962,5.32995951417004,12.977675737453291,"['CEBPB', 'DDIT3']",0.6459417943792497,0,0,2
60,Adipogenesis WP236,0.09347000204661088,1.696307094266278,4.020442427147737,"['SFRP4', 'CEBPB', 'TGFB1', 'WNT5B', 'GADD45A', 'DDIT3', 'NDN', 'IL6ST', 'RXRG', 'AGT']",0.6717821309173555,0,0,10
61,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.09439674403949562,3.199392097264438,7.55136103046433,"['BAX', 'PTHLH', 'BCL2L14']",0.6717821309173555,0,0,3
62,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.09574825773994491,1.916660145551295,4.496547658026735,"['MYO1E', 'CDKN1B', 'TRPC6', 'INF2', 'TGFB1', 'FAT1', 'VIM']",0.6717821309173555,0,0,7
63,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.10021570131821315,2.5102016465815535,5.774544185017418,"['RAB3B', 'RAB3A', 'HSPB1', 'RAB11A']",0.68115359489723,0,0,4
64,Lung fibrosis WP3624,0.10021570131821315,2.5102016465815535,5.774544185017418,"['CEBPB', 'TGFB1', 'FAM13A', 'FGF1']",0.68115359489723,0,0,4
65,Parkinson's disease pathway WP2371,0.10989884342969902,2.1342131979695433,4.712758787775989,"['PINK1', 'CASP6', 'HTRA2', 'CYCS', 'UBE2L6']",0.7354768752602935,0,0,5
66,Vitamin B12 metabolism WP1533,0.11279501901892756,2.908261950815142,6.346360075157314,"['PLAT', 'APOE', 'LDLR']",0.741154388989274,0,0,3
67,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.11585861712935777,4.263562753036437,9.189617708321048,"['GALNT3', 'FGFR2']",0.741154388989274,0,0,2
68,Osteoclast Signaling WP12,0.11585861712935777,4.263562753036437,9.189617708321048,"['AIMP2', 'ATP6V1G1']",0.741154388989274,0,0,2
69,Fas ligand pathway and stress induction of heat shock proteins WP314,0.12229459795257762,2.051932838734869,4.311772453182192,"['CASP6', 'RIPK2', 'HSPB1', 'CYCS', 'ACTG1']",0.7680323471912232,0,0,5
70,Exercise-induced Circadian Regulation WP410,0.12440827991278978,1.8834289813486371,3.925417335942089,"['PER2', 'DNAJA1', 'IDI1', 'CEBPB', 'RBPMS', 'HERPUD1']",0.7680323471912232,0,0,6
71,Gastric Cancer Network 1 WP2361,0.1324193702053833,2.6656534954407296,5.389368510742863,"['ACTL6A', 'GATD3B', 'KIF15']",0.7680323471912232,0,0,3
72,One-carbon metabolism WP241,0.1324193702053833,2.6656534954407296,5.389368510742863,"['ALDH1L1', 'AHCY', 'CHDH']",0.7680323471912232,0,0,3
73,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.1324193702053833,2.6656534954407296,5.389368510742863,"['HMGCS1', 'HMGCR', 'LDLR']",0.7680323471912232,0,0,3
74,Striated Muscle Contraction Pathway WP383,0.1324193702053833,2.6656534954407296,5.389368510742863,"['TNNT2', 'VIM', 'ACTG1']",0.7680323471912232,0,0,3
75,Type II interferon signaling (IFNG) WP619,0.1324193702053833,2.6656534954407296,5.389368510742863,"['PRKCD', 'HLA-B', 'IFIT2']",0.7680323471912232,0,0,3
76,DNA damage response WP707,0.13580179831162406,1.8294425087108015,3.652589579361186,"['CDKN1B', 'GADD45A', 'CYCS', 'BAX', 'BBC3', 'GADD45G']",0.7772866087573219,0,0,6
77,Galanin receptor pathway WP4970,0.14598807367667913,3.5526315789473686,6.836081498608301,"['CDKN1B', 'PRKCD']",0.7840100253006842,0,0,2
78,Leptin and adiponectin WP3934,0.14598807367667913,3.5526315789473686,6.836081498608301,"['LEPR', 'ADIPOR1']",0.7840100253006842,0,0,2
79,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.14598807367667913,3.5526315789473686,6.836081498608301,"['SFRP1', 'TGFB1']",0.7840100253006842,0,0,2
80,Matrix Metalloproteinases WP129,0.14598807367667913,3.5526315789473686,6.836081498608301,"['TIMP2', 'TIMP3']",0.7840100253006842,0,0,2
81,miR-509-3p alteration of YAP1/ECM axis WP3967,0.14598807367667913,3.5526315789473686,6.836081498608301,"['PBX3', 'FN1']",0.7840100253006842,0,0,2
82,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.15312131142210408,2.4603694178162265,4.616944196836107,"['FGF1', 'RUNX2', 'FGFR2']",0.8025032586580154,0,0,3
83,Methionine De Novo and Salvage Pathway WP3580,0.15312131142210408,2.4603694178162265,4.616944196836107,"['AHCY', 'CHDH', 'SRM']",0.8025032586580154,0,0,3
84,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.15988862335146697,1.5813532473410274,2.899059818429418,"['IDI1', 'SQLE', 'HMGCS1', 'INSIG1', 'CYP51A1', 'HMGCR', 'LDLR', 'FDFT1']",0.8187188385591333,0,0,8
85,miRNA regulation of DNA damage response WP1530,0.15997954316672722,1.73022412656559,3.170997894782874,"['CDKN1B', 'GADD45A', 'CYCS', 'BAX', 'BBC3', 'GADD45G']",0.8187188385591333,0,0,6
86,Drug Induction of Bile Acid Pathway WP2289,0.16441443265535513,10.652173913043478,19.231062066653926,['ABCB1'],0.8212617951322794,0,0,1
87,EV release from cardiac cells and their functional effects WP3297,0.16441443265535513,10.652173913043478,19.231062066653926,['RGS16'],0.8212617951322794,0,0,1
88,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.17271927013397664,1.6845314505776636,2.9581849917907603,"['SFRP4', 'SFRP1', 'WNT5B', 'TCF7', 'ROR2', 'CXXC4']",0.8212617951322794,0,0,6
89,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.17475184950736614,2.2844116369952236,3.9849009643765956,"['TGFBR3', 'ANGPT2', 'RUNX2']",0.8212617951322794,0,0,3
90,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.17475184950736614,2.2844116369952236,3.9849009643765956,"['HTR7', 'RPS6KA5', 'HTR4']",0.8212617951322794,0,0,3
91,Sleep regulation WP3591,0.17475184950736614,2.2844116369952236,3.9849009643765956,"['AHCY', 'CRH', 'HCRTR2']",0.8212617951322794,0,0,3
92,Alanine and aspartate metabolism WP106,0.17746806607456153,3.0448235974551765,5.264392200125727,"['GAD1', 'GAD2']",0.8212617951322794,0,0,2
93,Development and heterogeneity of the ILC family WP3893,0.17746806607456153,3.0448235974551765,5.264392200125727,"['NFIL3', 'IL7']",0.8212617951322794,0,0,2
94,Major receptors targeted by epinephrine and norepinephrine WP4589,0.17746806607456153,3.0448235974551765,5.264392200125727,"['ADCY10', 'ADRA1D']",0.8212617951322794,0,0,2
95,IL-6 signaling pathway WP364,0.1928406844077934,1.720157196659571,2.8311910771611,"['PRKCD', 'GAB1', 'VIP', 'IL6ST', 'AGT']",0.8349562188655456,0,0,5
96,White fat cell differentiation WP4149,0.19716411404481132,2.1319148936170214,3.461630358501204,"['CEBPB', 'DDIT3', 'NR2F2']",0.8349562188655456,0,0,3
97,Proximal tubule transport WP4917,0.1978015902144662,1.8543081400476233,3.004889318989852,"['ATP6V1G1', 'ABCB1', 'CA4', 'SLC3A1']",0.8349562188655456,0,0,4
98,Acute viral myocarditis WP4298,0.1993773811674985,1.6,2.580089379767168,"['ENDOG', 'CXADR', 'TGFB1', 'CASP6', 'CYCS', 'BAX']",0.8349562188655456,0,0,6
99,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.20240974037076098,1.5240517366661823,2.4346135441065098,"['TGFB1', 'GADD45A', 'TCF7', 'CYCS', 'BAX', 'BBC3', 'GADD45G']",0.8349562188655456,0,0,7
100,Spinal Cord Injury WP2431,0.20240974037076098,1.5240517366661823,2.4346135441065098,"['TGFB1', 'CDKN1B', 'GADD45A', 'APEX1', 'AQP4', 'VIM', 'GFAP']",0.8349562188655456,0,0,7
101,Differentiation of white and brown adipocyte WP2895,0.2098449429723246,2.6639676113360324,4.159482765853906,"['CEBPB', 'SMAD9']",0.8349562188655456,0,0,2
102,"GPCRs, Class B Secretin-like WP334",0.2098449429723246,2.6639676113360324,4.159482765853906,"['VIPR2', 'ADGRG2']",0.8349562188655456,0,0,2
103,Kynurenine Pathway and links to Cellular Senescence WP5044,0.2098449429723246,2.6639676113360324,4.159482765853906,"['KMO', 'ACMSD']",0.8349562188655456,0,0,2
104,Osteoblast differentiation WP4787,0.21490066720168552,1.446649867099313,2.2243389921776755,"['PRKCH', 'WNT5B', 'PRKCD', 'SMAD9', 'FGF1', 'RUNX2', 'FGFR2', 'GLI3']",0.8349562188655456,0,0,8
105,Pyrimidine metabolism WP4022,0.21490066720168552,1.446649867099313,2.2243389921776755,"['NT5C', 'NME6', 'POLE2', 'POLR1C', 'POLE3', 'POLR2E', 'POLR2I', 'POLR2K']",0.8349562188655456,0,0,8
106,DNA Replication WP466,0.2162567027434939,1.7768762677484786,2.7209113289149194,"['DBF4', 'RPA3', 'POLE2', 'GMNN']",0.8349562188655456,0,0,4
107,GABA receptor Signaling WP4159,0.2162567027434939,1.7768762677484786,2.7209113289149194,"['SLC32A1', 'GAD1', 'GAD2', 'GABRD']",0.8349562188655456,0,0,4
108,Tumor suppressor activity of SMARCB1 WP4204,0.2162567027434939,1.7768762677484786,2.7209113289149194,"['H3F3B', 'CDKN2A', 'ACTL6A', 'GLI3']",0.8349562188655456,0,0,4
109,Angiogenesis WP1539,0.22021541642586265,1.9984802431610942,3.0239984736440255,"['TIMP2', 'TIMP3', 'FGFR2']",0.8349562188655456,0,0,3
110,DNA Mismatch Repair WP531,0.22021541642586265,1.9984802431610942,3.0239984736440255,"['RPA3', 'POLE2', 'POLE3']",0.8349562188655456,0,0,3
111,IL-7 signaling pathway WP205,0.22021541642586265,1.9984802431610942,3.0239984736440255,"['CDKN1B', 'IL7', 'PTK2B']",0.8349562188655456,0,0,3
112,Neural Crest Differentiation WP2064,0.2274286866241437,1.5235191637630663,2.2562077986977154,"['DLX5', 'LHX2', 'ASCL1', 'ETS1', 'FGFR2', 'GFAP']",0.8349562188655456,0,0,6
113,T-cell receptor (TCR) signaling pathway WP69,0.22783071992820045,1.4640057447190473,2.1654875849145925,"['TGFB1', 'RIPK2', 'PRKCD', 'PTK2B', 'LCP2', 'CD247', 'VIM']",0.8349562188655456,0,0,7
114,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.23619754950000163,5.325581395348837,7.685275947435609,['ABCB1'],0.8349562188655456,0,0,1
115,miR-517 relationship with ARCN1 and USP1 WP3596,0.23619754950000163,5.325581395348837,7.685275947435609,['ARCN1'],0.8349562188655456,0,0,1
116,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.23619754950000163,5.325581395348837,7.685275947435609,['CD247'],0.8349562188655456,0,0,1
117,Platelet-mediated interactions with vascular and circulating cells WP4462,0.23619754950000163,5.325581395348837,7.685275947435609,['TGFB1'],0.8349562188655456,0,0,1
118,Tgif disruption of Shh signaling WP3674,0.23619754950000163,5.325581395348837,7.685275947435609,['GLI3'],0.8349562188655456,0,0,1
119,Vitamin B6-dependent and responsive disorders WP4228,0.23619754950000163,5.325581395348837,7.685275947435609,['PNPO'],0.8349562188655456,0,0,1
120,Eukaryotic Transcription Initiation WP405,0.24065986262437036,1.5679307255897283,2.2333145864156014,"['GTF2A2', 'POLR2E', 'TAF7', 'POLR2I', 'POLR2K']",0.8349562188655456,0,0,5
121,G1 to S cell cycle control WP45,0.24065986262437036,1.5679307255897283,2.2333145864156014,"['CDKN1B', 'CDKN2A', 'GADD45A', 'RPA3', 'POLE2']",0.8349562188655456,0,0,5
122,BMP Signaling Pathway in Eyelid Development WP3927,0.242732885275225,2.3677462887989202,3.35224022630837,"['SFRP1', 'FGFR2']",0.8349562188655456,0,0,2
123,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.242732885275225,2.3677462887989202,3.35224022630837,"['IL6ST', 'SOX4']",0.8349562188655456,0,0,2
124,Overview of nanoparticle effects WP3287,0.242732885275225,2.3677462887989202,3.35224022630837,"['FN1', 'BAX']",0.8349562188655456,0,0,2
125,Tryptophan catabolism leading to NAD+ production WP4210,0.242732885275225,2.3677462887989202,3.35224022630837,"['NMNAT1', 'KMO']",0.8349562188655456,0,0,2
126,TYROBP causal network in microglia WP3945,0.242732885275225,2.3677462887989202,3.35224022630837,"['LOXL3', 'LHFPL2']",0.8349562188655456,0,0,2
127,NRF2-ARE regulation WP4357,0.24376882711706732,1.8807437868764527,2.6547355545073805,"['AIMP2', 'CEBPB', 'SLC7A11']",0.8349562188655456,0,0,3
128,Apoptosis WP254,0.2566473796207337,1.4539911308203992,1.9775038361957724,"['HRK', 'CASP6', 'CDKN2A', 'CYCS', 'BAX', 'BBC3']",0.8654388382559626,0,0,6
129,Endometrial cancer WP4155,0.2566473796207337,1.4539911308203992,1.9775038361957724,"['GADD45A', 'TCF7', 'BAX', 'FGF1', 'FGFR2', 'GADD45G']",0.8654388382559626,0,0,6
130,Integrated Cancer Pathway WP1971,0.2739986442228702,1.5789948163173315,2.044217407620093,"['CDKN1B', 'BAX', 'BACH1', 'BBC3']",0.8887069943460528,0,0,4
131,p38 MAPK Signaling Pathway WP400,0.2739986442228702,1.5789948163173315,2.044217407620093,"['RPS6KA5', 'DDIT3', 'HSPB1', 'HMGN1']",0.8887069943460528,0,0,4
132,p53 transcriptional gene network WP4963,0.27413742973173366,1.4805414551607445,1.916006791415842,"['GADD45A', 'BAX', 'SLC7A11', 'BBC3', 'RPRM']",0.8887069943460528,0,0,5
133,Airway smooth muscle cell contraction WP4962,0.2758056189349819,2.1307692307692307,2.744556358062996,"['PPP1R14A', 'MYLK']",0.8887069943460528,0,0,2
134,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.2758056189349819,2.1307692307692307,2.744556358062996,"['CD81', 'HSPB1']",0.8887069943460528,0,0,2
135,GDNF/RET signaling axis WP4830,0.2758056189349819,2.1307692307692307,2.744556358062996,"['SALL1', 'GLI3']",0.8887069943460528,0,0,2
136,Aryl Hydrocarbon Receptor Netpath WP2586,0.29381170380945587,1.5224572587655751,1.8647302839870714,"['HSP90AA1', 'CDKN1B', 'AIP', 'CD36']",0.9100168814143583,0,0,4
137,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.301819645121103,3.55005055611729,4.25269659010989,['APOE'],0.9100168814143583,0,0,1
138,Bile acids synthesis and enterohepatic circulation  WP4389,0.301819645121103,3.55005055611729,4.25269659010989,['LDLR'],0.9100168814143583,0,0,1
139,Blood Clotting Cascade WP272,0.301819645121103,3.55005055611729,4.25269659010989,['PLAT'],0.9100168814143583,0,0,1
140,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.301819645121103,3.55005055611729,4.25269659010989,['RUNX2'],0.9100168814143583,0,0,1
141,FOXP3 in COVID-19 WP5063,0.301819645121103,3.55005055611729,4.25269659010989,['IL6ST'],0.9100168814143583,0,0,1
142,mir-124 predicted interactions with cell cycle and differentiation  WP3595,0.301819645121103,3.55005055611729,4.25269659010989,['STRADB'],0.9100168814143583,0,0,1
143,Role of Osx and miRNAs in tooth development WP3971,0.301819645121103,3.55005055611729,4.25269659010989,['RUNX2'],0.9100168814143583,0,0,1
144,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.30215276152268805,1.3607939802802282,1.628628930540663,"['SFRP4', 'SFRP1', 'WNT5B', 'TCF7', 'ROR2', 'CXXC4']",0.9100168814143583,0,0,6
145,Apoptosis Modulation by HSP70 WP384,0.3087890485489286,1.936878910563121,2.276020453844744,"['CASP6', 'CYCS']",0.9100168814143583,0,0,2
146,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.3087890485489286,1.936878910563121,2.276020453844744,"['FGFR2', 'GADD45G']",0.9100168814143583,0,0,2
147,Small cell lung cancer WP4658,0.3095029214288679,1.309150291802752,1.535355422141752,"['CDKN1B', 'GADD45A', 'FN1', 'CYCS', 'BAX', 'RXRG', 'GADD45G']",0.9100168814143583,0,0,7
148,One-carbon metabolism and related pathways WP3940,0.3137989246256408,1.46981884311394,1.7035242511274216,"['CHDH', 'GAD1', 'GAD2', 'PLD1']",0.9100168814143583,0,0,4
149,Prader-Willi and Angelman Syndrome WP3998,0.3137989246256408,1.46981884311394,1.7035242511274216,"['DLX5', 'CDKN2A', 'NDN', 'GABRD']",0.9100168814143583,0,0,4
150,TGF-beta Receptor Signaling WP560,0.3137989246256408,1.46981884311394,1.7035242511274216,"['TGFBR3', 'TGFB1', 'SMAD9', 'RUNX2']",0.9100168814143583,0,0,4
151,Proteasome Degradation WP183,0.3176509256171025,1.3323170731707317,1.5279041736868921,"['PSMD8', 'H2AFZ', 'HLA-B', 'HLA-C', 'HLA-A', 'HLA-F']",0.9150871035989376,0,0,6
152,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.3259052037952018,1.3662631784459196,1.5317842216304856,"['IFI27L2', 'PRKCH', 'PRKCD', 'ETS1', 'RXRG']",0.9247050324739737,0,0,5
153,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.33326554796952496,1.3050024888003982,1.4339571781310063,"['PSMD8', 'TUBB2B', 'TUBB2A', 'HSPA5', 'UBE2L6', 'HSPA1B']",0.9247050324739737,0,0,6
154,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.3405231760169237,1.521927920104212,1.6395304729154467,"['ANGPT2', 'IGFBP3', 'BAX']",0.9247050324739737,0,0,3
155,The influence of laminopathies on Wnt signaling WP4844,0.3405231760169237,1.521927920104212,1.6395304729154467,"['CEBPB', 'TCF7', 'RUNX2']",0.9247050324739737,0,0,3
156,DNA damage response (only ATM dependent) WP710,0.34097823458219173,1.2358097936774994,1.3296530271283826,"['TGFB1', 'CDKN1B', 'WNT5B', 'CDKN2A', 'TCF7', 'BAX', 'LDLR', 'BBC3']",0.9247050324739737,0,0,8
157,Complement and Coagulation Cascades WP558,0.34145471527321286,1.7753036437246963,1.907635157444345,"['F2R', 'PLAT']",0.9247050324739737,0,0,2
158,miRNA regulation of p53 pathway in prostate cancer WP3982,0.34145471527321286,1.7753036437246963,1.907635157444345,"['BAX', 'BBC3']",0.9247050324739737,0,0,2
159,Pregnane X receptor pathway WP2876,0.34145471527321286,1.7753036437246963,1.907635157444345,"['HSP90AA1', 'ABCB1']",0.9247050324739737,0,0,2
160,Transcription co-factors SKI and SKIL protein partners WP4533,0.34145471527321286,1.7753036437246963,1.907635157444345,"['SATB2', 'MERTK']",0.9247050324739737,0,0,2
161,Synaptic Vesicle Pathway WP2267,0.36097582939208833,1.2993685774421195,1.323984176326352,"['RAB3A', 'SLC32A1', 'SLC1A3', 'SLC17A7', 'CPLX3']",0.9247050324739737,0,0,5
162,Farnesoid X receptor pathway WP2879,0.3618090164544497,2.6622851365015165,2.7065823271092375,['FKBP5'],0.9247050324739737,0,0,1
163,Inflammatory Response Pathway WP453,0.3618090164544497,2.6622851365015165,2.7065823271092375,['FN1'],0.9247050324739737,0,0,1
164,Linoleic acid metabolism known to be affected by coronavirus infection WP4853,0.3618090164544497,2.6622851365015165,2.7065823271092375,['ACOT2'],0.9247050324739737,0,0,1
165,Peroxiredoxin 2 induced ovarian failure WP4873,0.3618090164544497,2.6622851365015165,2.7065823271092375,['BAX'],0.9247050324739737,0,0,1
166,Non-small cell lung cancer WP4255,0.3647312268464241,1.2535868005738882,1.2643608293689585,"['CDKN2A', 'GADD45A', 'CYCS', 'BAX', 'RXRG', 'GADD45G']",0.9247050324739737,0,0,6
167,Bladder cancer WP2828,0.36479943993317354,1.4526112185686655,1.4648241288135162,"['RPS6KA5', 'CDKN2A', 'DAPK2']",0.9247050324739737,0,0,3
168,Nuclear receptors WP170,0.36479943993317354,1.4526112185686655,1.4648241288135162,"['NR2E1', 'NR2F2', 'RXRG']",0.9247050324739737,0,0,3
169,Oxidative Damage WP3941,0.36479943993317354,1.4526112185686655,1.4648241288135162,"['CDKN1B', 'GADD45A', 'CYCS']",0.9247050324739737,0,0,3
170,Glioblastoma signaling pathways WP2261,0.3667227556505032,1.2228374164067841,1.2266883155984074,"['CDKN1B', 'PRKCH', 'CDKN2A', 'PRKCD', 'GAB1', 'SPRY2', 'FGFR2']",0.9247050324739737,0,0,7
171,Canonical and non-canonical Notch signaling WP3845,0.37361399195278566,1.6385861102460293,1.613240659602157,"['MAML2', 'PSEN2']",0.9247050324739737,0,0,2
172,Constitutive Androstane Receptor Pathway WP2875,0.37361399195278566,1.6385861102460293,1.613240659602157,"['HSP90AA1', 'ABCB1']",0.9247050324739737,0,0,2
173,Hematopoietic Stem Cell Differentiation WP2849,0.37361399195278566,1.6385861102460293,1.613240659602157,"['PIM1', 'RUNX1']",0.9247050324739737,0,0,2
174,Vitamin A and carotenoid metabolism WP716,0.37361399195278566,1.6385861102460293,1.613240659602157,"['CD36', 'RXRG']",0.9247050324739737,0,0,2
175,Base Excision Repair WP4752,0.3889221665287065,1.3893220562970794,1.3120424637944867,"['APEX1', 'POLE2', 'POLE3']",0.9247050324739737,0,0,3
176,Complement system WP2806,0.3889221665287065,1.3893220562970794,1.3120424637944867,"['PRNP', 'CALR', 'DCN']",0.9247050324739737,0,0,3
177,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.39430043679132837,1.2911672505992993,1.2016146407167902,"['TGFBR3', 'TGFB1', 'SMAD9', 'RUNX2']",0.9247050324739737,0,0,4
178,Pancreatic adenocarcinoma pathway WP4263,0.3956490358097036,1.1837911156324177,1.0976439535680087,"['TGFB1', 'CDKN2A', 'GADD45A', 'PRKCD', 'BAX', 'PLD1', 'GADD45G']",0.9247050324739737,0,0,7
179,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.4051129371303559,1.5213996529786002,1.3747205899145152,"['H3F3B', 'H2AFZ']",0.9247050324739737,0,0,2
180,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.4051129371303559,1.5213996529786002,1.3747205899145152,"['BAX', 'BBC3']",0.9247050324739737,0,0,2
181,Nucleotide metabolism WP404,0.4051129371303559,1.5213996529786002,1.3747205899145152,"['PRPS1', 'SRM']",0.9247050324739737,0,0,2
182,Ovarian infertility WP34,0.4051129371303559,1.5213996529786002,1.3747205899145152,"['CEBPB', 'CDKN1B']",0.9247050324739737,0,0,2
183,Pre-implantation embryo WP3527,0.4051129371303559,1.5213996529786002,1.3747205899145152,"['DLX2', 'DDIT3']",0.9247050324739737,0,0,2
184,Proteoglycan biosynthesis WP4784,0.4051129371303559,1.5213996529786002,1.3747205899145152,"['B4GALT7', 'PAPSS2']",0.9247050324739737,0,0,2
185,Ebola Virus Pathway on Host WP4217,0.4078941836547234,1.1517586833269113,1.032836710666578,"['VPS4A', 'HLA-B', 'HLA-C', 'HLA-A', 'HLA-F', 'MERTK', 'ASGR1', 'ACTG1']",0.9247050324739737,0,0,8
186,BDNF-TrkB Signaling WP3676,0.4128122311790752,1.331306990881459,1.1778904155964935,"['TRPC6', 'TRPC3', 'GAB1']",0.9247050324739737,0,0,3
187,Glucocorticoid Receptor Pathway WP2880,0.4142936656672686,1.2530724257248538,1.1041826348452646,"['TGFBR3', 'RGS2', 'HSP90AA1', 'B3GNT5']",0.9247050324739737,0,0,4
188,Ectoderm Differentiation WP2858,0.41504114542427245,1.1214822771213748,0.9862064135575358,"['MAFB', 'PIM1', 'SPRY2', 'ROR2', 'NR2F2', 'ARHGAP15', 'JAKMIP1', 'PTPN13', 'FGFR2', 'GLI3']",0.9247050324739737,0,0,10
189,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.4166487042871238,2.1296258847320524,1.8645126938777297,['TCF7'],0.9247050324739737,0,0,1
190,Cellular Proteostasis WP4918,0.4166487042871238,2.1296258847320524,1.8645126938777297,['VBP1'],0.9247050324739737,0,0,1
191,"Degradation pathway of sphingolipids, including diseases WP4153",0.4166487042871238,2.1296258847320524,1.8645126938777297,['NEU1'],0.9247050324739737,0,0,1
192,Disorders of Folate Metabolism and Transport WP4259,0.4166487042871238,2.1296258847320524,1.8645126938777297,['ALDH1L1'],0.9247050324739737,0,0,1
193,Eicosanoid Synthesis WP167,0.4166487042871238,2.1296258847320524,1.8645126938777297,['PTGES2'],0.9247050324739737,0,0,1
194,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.4166487042871238,2.1296258847320524,1.8645126938777297,['AHCY'],0.9247050324739737,0,0,1
195,Methylation Pathways WP704,0.4166487042871238,2.1296258847320524,1.8645126938777297,['NNMT'],0.9247050324739737,0,0,1
196,Selective expression of chemokine receptors during T-cell polarization WP4494,0.4166487042871238,2.1296258847320524,1.8645126938777297,['TGFB1'],0.9247050324739737,0,0,1
197,MECP2 and Associated Rett Syndrome WP3584,0.427857353553214,1.1619733924611972,0.9864752350196099,"['DLX5', 'SST', 'GAD1', 'OPRK1', 'SGK1', 'FKBP5']",0.9432092834876258,0,0,6
198,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.4341375220545141,1.217154447986091,1.0155862759465581,"['CEBPB', 'TGFB1', 'TCF7', 'RUNX2']",0.9432092834876258,0,0,4
199,Differentiation Pathway WP2848,0.43582773788738577,1.419838056680162,1.179187163359175,"['TGFB1', 'FGF1']",0.9432092834876258,0,0,2
200,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.43582773788738577,1.419838056680162,1.179187163359175,"['PLAT', 'TIRAP']",0.9432092834876258,0,0,2
201,NAD+ biosynthetic pathways WP3645,0.43582773788738577,1.419838056680162,1.179187163359175,"['NMNAT1', 'ACMSD']",0.9432092834876258,0,0,2
202,VEGFA-VEGFR2 Signaling Pathway WP3888,0.43969463923493124,1.0447303921568627,0.8584286305334058,"['SET', 'TRAF3IP2', 'HSPB1', 'RPL10A', 'ETS1', 'APOLD1', 'HERPUD1', 'ACTG1', 'RPS6KA5', 'RPL18A', 'RPLP2', 'DNAJB9', 'PTK2B', 'IGFBP7', 'MYH11', 'IER5', 'TXNDC5', 'HSP90AA1', 'TRPC3', 'IGFBP3', 'PRKCD', 'FN1', 'GAB1', 'RAB11A', 'DNAJA1', 'RCN1', 'PTPN9', 'CYCS', 'CALR', 'ARF6']",0.9468671686494807,0,0,30
203,Myometrial relaxation and contraction pathways WP289,0.45066140112188047,1.086838817159517,0.8662529185740119,"['RGS2', 'PRKCH', 'IGFBP5', 'IGFBP3', 'RGS16', 'PRKCD', 'CRH', 'ATF5', 'CORIN', 'ACTG1']",0.9657030024040295,0,0,10
204,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.4656606783769296,1.3309716599190284,1.0172590683476135,"['B3GALNT1', 'B3GALT1']",0.9739646668579933,0,0,2
205,Oxidation by Cytochrome P450 WP43,0.4656606783769296,1.3309716599190284,1.0172590683476135,"['CYB5R1', 'CYP51A1']",0.9739646668579933,0,0,2
206,Cancer immunotherapy by PD-1 blockade WP4585,0.4667803646706122,1.7745197168857432,1.352000260580725,['HLA-A'],0.9739646668579933,0,0,1
207,Dual hijack model of Vif in HIV infection WP3300,0.4667803646706122,1.7745197168857432,1.352000260580725,['RUNX1'],0.9739646668579933,0,0,1
208,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.4667803646706122,1.7745197168857432,1.352000260580725,['TGFB1'],0.9739646668579933,0,0,1
209,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.4732116355886376,1.1511430294391756,0.8612996707083834,"['PPP1R14A', 'XBP1', 'HSPA5', 'DDIT3']",0.9739646668579933,0,0,4
210,Modulators of TCR signaling and T cell activation WP5072,0.4732116355886376,1.1511430294391756,0.8612996707083834,"['CDKN1B', 'LCP2', 'CD247', 'ZFP36L1']",0.9739646668579933,0,0,4
211,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.4732116355886376,1.1511430294391756,0.8612996707083834,"['EIF4A2', 'RPS6KA5', 'PRKCD', 'PIM1']",0.9739646668579933,0,0,4
212,Breast cancer pathway WP4262,0.474667837641137,1.07834695403336,0.8035194587540014,"['SFRP4', 'SHC3', 'WNT5B', 'GADD45A', 'TCF7', 'BAX', 'FGF1', 'GADD45G']",0.9739646668579933,0,0,8
213,Nonalcoholic fatty liver disease WP4396,0.4795634559424677,1.0552687518979653,0.7754949038860949,"['XBP1', 'NDUFA7', 'TGFB1', 'NDUFB11', 'DDIT3', 'LEPR', 'CYCS', 'BAX', 'ADIPOR1', 'COX7A1', 'BBC3']",0.9760569301024128,0,0,11
214,Cell cycle WP179,0.48180328749895523,1.0802335353177939,0.788807446704181,"['TGFB1', 'CDKN1B', 'DBF4', 'GADD45A', 'CDKN2A', 'CDC14B', 'GADD45G']",0.9760569301024128,0,0,7
215,Ferroptosis WP4313,0.4824189424644109,1.1830462681526512,0.8623725472240579,"['PRNP', 'VDAC3', 'SLC7A11']",0.9760569301024128,0,0,3
216,Wnt signaling pathway and pluripotency WP399,0.4899461355191807,1.082782141380736,0.7725215532390556,"['PRKCH', 'WNT5B', 'PRKCD', 'TCF7', 'ZBTB33', 'LDLR']",0.9778336877501714,0,0,6
217,Phosphodiesterases in neuronal function WP4222,0.49236778225679634,1.1207430340557276,0.7940792962673466,"['ADCY10', 'PDE10A', 'PDE5A', 'PDE6B']",0.9778336877501714,0,0,4
218,Glycerolipids and Glycerophospholipids WP4722,0.49453657771273035,1.2525601333650869,0.8819703793224667,"['PLD1', 'CDIPT']",0.9778336877501714,0,0,2
219,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.49453657771273035,1.2525601333650869,0.8819703793224667,"['HSP90AA1', 'RIPK2']",0.9778336877501714,0,0,2
220,PKC-gamma calcium signaling pathway in ataxia WP4760,0.49453657771273035,1.2525601333650869,0.8819703793224667,"['GNA14', 'TRPC3']",0.9778336877501714,0,0,2
221,Melanoma WP4685,0.4995098574405563,1.0863980109810423,0.7540992204141069,"['CDKN2A', 'GADD45A', 'BAX', 'ETS1', 'GADD45G']",0.9794993364993301,0,0,5
222,Target Of Rapamycin (TOR) Signaling WP1471,0.5047496778132077,1.140686061658706,0.7798786878333348,"['IDI1', 'RRAGA', 'HMGCR']",0.9794993364993301,0,0,3
223,Mitochondrial CII Assembly WP4920,0.5126078109713544,1.5208724541383793,1.0163142378186307,['SDHAF1'],0.9794993364993301,0,0,1
224,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.5126078109713544,1.5208724541383793,1.0163142378186307,['RNASEH2C'],0.9794993364993301,0,0,1
225,Serotonin and anxiety-related events WP3944,0.5126078109713544,1.5208724541383793,1.0163142378186307,['CRH'],0.9794993364993301,0,0,1
226,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.5126078109713544,1.5208724541383793,1.0163142378186307,['TGFB1'],0.9794993364993301,0,0,1
227,Trans-sulfuration pathway WP2333,0.5126078109713544,1.5208724541383793,1.0163142378186307,['AHCY'],0.9794993364993301,0,0,1
228,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.5175201015875719,1.0301864456939922,0.6785909313451611,"['DLX2', 'CEBPB', 'VIPR2', 'SST', 'PAH', 'SLC1A3', 'AQP4', 'TAC1', 'ASCL1']",0.9794993364993301,0,0,9
229,Cell migration and invasion through p75NTR WP4561,0.5223996461329761,1.1828609986504723,0.7680581169689005,"['EFNA3', 'EFNB3']",0.9794993364993301,0,0,2
230,Endothelin Pathways WP2197,0.5223996461329761,1.1828609986504723,0.7680581169689005,"['ADCY10', 'MYLK']",0.9794993364993301,0,0,2
231,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.5223996461329761,1.1828609986504723,0.7680581169689005,"['TGFBR3', 'TGFB1']",0.9794993364993301,0,0,2
232,Physiological and pathological hypertrophy of the heart WP1528,0.5223996461329761,1.1828609986504723,0.7680581169689005,"['IL6ST', 'AGT']",0.9794993364993301,0,0,2
233,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.526570835936835,1.1012472487160676,0.7063063039738479,"['HSP90AA1', 'CDKN2A', 'BAX']",0.983082891126709,0,0,3
234,Wnt signaling WP428,0.5350294324872265,1.0300944138473642,0.6442555747775213,"['SFRP4', 'SFRP1', 'WNT5B', 'TCF7', 'ROR2', 'CXXC4']",0.9842308947669456,0,0,6
235,15q11.2 copy number variation syndrome WP4940,0.554500253124379,1.3306370070778564,0.7846606963215317,['TUBGCP4'],0.9842308947669456,0,0,1
236,Biomarkers for pyrimidine metabolism disorders WP4584,0.554500253124379,1.3306370070778564,0.7846606963215317,['NT5C'],0.9842308947669456,0,0,1
237,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.554500253124379,1.3306370070778564,0.7846606963215317,['SOX4'],0.9842308947669456,0,0,1
238,Hypertrophy Model WP516,0.554500253124379,1.3306370070778564,0.7846606963215317,['WDR1'],0.9842308947669456,0,0,1
239,miRNAs involved in DNA damage response WP1545,0.554500253124379,1.3306370070778564,0.7846606963215317,['CDKN1B'],0.9842308947669456,0,0,1
240,Purine metabolism WP4792,0.554500253124379,1.3306370070778564,0.7846606963215317,['PRPS1'],0.9842308947669456,0,0,1
241,Pyrimidine metabolism and related diseases WP4225,0.554500253124379,1.3306370070778564,0.7846606963215317,['NT5C'],0.9842308947669456,0,0,1
242,RAS and bradykinin pathways in COVID-19 WP4969,0.554500253124379,1.3306370070778564,0.7846606963215317,['AGT'],0.9842308947669456,0,0,1
243,Retinoblastoma gene in cancer WP2446,0.5645181879766666,1.0040226031989272,0.5740827311121096,"['ANLN', 'CDKN1B', 'H2AFZ', 'RPA3', 'POLE2']",0.9842308947669456,0,0,5
244,Cytosolic DNA-sensing pathway WP4655,0.5685527777184743,1.0300029414648495,0.5816026282347224,"['POLR1C', 'POLR2E', 'POLR2K']",0.9842308947669456,0,0,3
245,Genotoxicity pathway WP4286,0.5685527777184743,1.0300029414648495,0.5816026282347224,"['RPS27', 'GADD45A', 'PCDH8']",0.9842308947669456,0,0,3
246,Glycogen Synthesis and Degradation WP500,0.5685527777184743,1.0300029414648495,0.5816026282347224,"['PHKG1', 'PPP2R5B', 'GYG1']",0.9842308947669456,0,0,3
247,Ethanol effects on histone modifications WP3996,0.5749447937268437,1.0643724696356276,0.5891102089019137,"['AHCY', 'HAT1']",0.9842308947669456,0,0,2
248,MTHFR deficiency WP4288,0.5749447937268437,1.0643724696356276,0.5891102089019137,"['CHDH', 'CYCS']",0.9842308947669456,0,0,2
249,Oxysterols derived from cholesterol WP4545,0.5749447937268437,1.0643724696356276,0.5891102089019137,"['INSIG1', 'ACOT2']",0.9842308947669456,0,0,2
250,Pathways Regulating Hippo Signaling WP4540,0.5783382833795854,0.9822701688555348,0.5378875259274944,"['PRKCH', 'PRKD3', 'PRKCD', 'TCF7', 'FGFR2', 'CDH18']",0.9842308947669456,0,0,6
251,Interleukin-11 Signaling Pathway WP2332,0.5886622012448429,0.9977203647416414,0.5286947871264606,"['TGFB1', 'IL6ST', 'RUNX2']",0.9842308947669456,0,0,3
252,ESC Pluripotency Pathways WP3931,0.5923172043746479,0.9672949002217295,0.5065848844777232,"['WNT5B', 'GAB1', 'SMAD9', 'FGF1', 'IL6ST', 'FGFR2']",0.9842308947669456,0,0,6
253,Metapathway biotransformation Phase I and II WP702,0.5923172043746479,0.9672949002217295,0.5065848844777232,"['NNMT', 'CYP51A1', 'KCNAB1', 'SULT4A1', 'GAL3ST3', 'FMO5']",0.9842308947669456,0,0,6
254,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.5927952601497375,1.182676103808561,0.6184286681379344,['RUNX2'],0.9842308947669456,0,0,1
255,Canonical and non-canonical TGF-B signaling WP3874,0.5927952601497375,1.182676103808561,0.6184286681379344,['TGFB1'],0.9842308947669456,0,0,1
256,Cysteine and methionine catabolism WP4504,0.5927952601497375,1.182676103808561,0.6184286681379344,['AHCY'],0.9842308947669456,0,0,1
257,Fatty acid transporters WP5061,0.5927952601497375,1.182676103808561,0.6184286681379344,['CD36'],0.9842308947669456,0,0,1
258,Ganglio Sphingolipid Metabolism WP1423,0.5927952601497375,1.182676103808561,0.6184286681379344,['B3GALT1'],0.9842308947669456,0,0,1
259,Glycolysis in senescence WP5049,0.5927952601497375,1.182676103808561,0.6184286681379344,['ALDOC'],0.9842308947669456,0,0,1
260,Hedgehog Signaling Pathway Netpath WP47,0.5927952601497375,1.182676103808561,0.6184286681379344,['GLI3'],0.9842308947669456,0,0,1
261,Mammalian disorder of sexual development WP4842,0.5927952601497375,1.182676103808561,0.6184286681379344,['FGFR2'],0.9842308947669456,0,0,1
262,IL17 signaling pathway WP2112,0.5995889358925071,1.0135916714864084,0.5184632544082293,"['CEBPB', 'TRAF3IP2']",0.9842308947669456,0,0,2
263,Neovascularisation processes WP4331,0.5995889358925071,1.0135916714864084,0.5184632544082293,"['TGFB1', 'SMAD9']",0.9842308947669456,0,0,2
264,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.5995889358925071,1.0135916714864084,0.5184632544082293,"['TGFB1', 'BAX']",0.9842308947669456,0,0,2
265,Sphingolipid pathway WP1422,0.5995889358925071,1.0135916714864084,0.5184632544082293,"['CERS4', 'SERINC1']",0.9842308947669456,0,0,2
266,Pathogenic Escherichia coli infection WP2272,0.6081584291102166,0.9673943078198397,0.48110439860032983,"['TUBB2B', 'TUBB2A', 'ACTG1']",0.9894697065903604,0,0,3
267,PPAR signaling pathway WP3942,0.6270282374220709,0.9388521365993205,0.4382221004141413,"['SLC27A6', 'CD36', 'RXRG']",0.9894697065903604,0,0,3
268,Cell Differentiation - Index expanded WP2023,0.6278014690090563,1.0643073811931243,0.495468393067517,['RUNX2'],0.9894697065903604,0,0,1
269,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.6278014690090563,1.0643073811931243,0.495468393067517,['CCK'],0.9894697065903604,0,0,1
270,Cori Cycle WP1946,0.6278014690090563,1.0643073811931243,0.495468393067517,['PGAM1'],0.9894697065903604,0,0,1
271,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.6278014690090563,1.0643073811931243,0.495468393067517,['RPH3AL'],0.9894697065903604,0,0,1
272,Leptin Insulin Overlap WP3935,0.6278014690090563,1.0643073811931243,0.495468393067517,['LEPR'],0.9894697065903604,0,0,1
273,NOTCH1 regulation of endothelial cell calcification WP3413,0.6278014690090563,1.0643073811931243,0.495468393067517,['PLAT'],0.9894697065903604,0,0,1
274,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.6278014690090563,1.0643073811931243,0.495468393067517,['SFRP4'],0.9894697065903604,0,0,1
275,Riboflavin and CoQ disorders WP5037,0.6278014690090563,1.0643073811931243,0.495468393067517,['RFK'],0.9894697065903604,0,0,1
276,Serotonin and anxiety WP3947,0.6278014690090563,1.0643073811931243,0.495468393067517,['CRH'],0.9894697065903604,0,0,1
277,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.6328773636560044,0.9251256724578887,0.42322521032655686,"['ANGPT2', 'FN1', 'BAX', 'ANGPTL1']",0.993868784080729,0,0,4
278,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.6392429466965408,0.9170313320497112,0.4103446507798314,"['TGFB1', 'IL6ST', 'AGT', 'FGFR2', 'MYLK']",0.9991254480717237,0,0,5
279,Melatonin metabolism and effects WP3298,0.6456047577936928,0.9252772399225488,0.4048715193091868,"['PER2', 'APOE']",0.9991254480717237,0,0,2
280,AMP-activated protein kinase (AMPK) signaling WP1403,0.6485737399214706,0.9053558327219369,0.3920005820939097,"['STRADB', 'LEPR', 'HMGCR', 'ADIPOR1']",0.9991254480717237,0,0,4
281,ERK Pathway in Huntington's Disease WP3853,0.6598010621901383,0.9674602445077672,0.4022863297306986,['RPS6KA5'],0.9991254480717237,0,0,1
282,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.6598010621901383,0.9674602445077672,0.4022863297306986,['ABCB1'],0.9991254480717237,0,0,1
283,Omega-3/Omega-6 FA synthesis WP4723,0.6598010621901383,0.9674602445077672,0.4022863297306986,['ACOT2'],0.9991254480717237,0,0,1
284,Type II diabetes mellitus WP1584,0.6598010621901383,0.9674602445077672,0.4022863297306986,['PRKCD'],0.9991254480717237,0,0,1
285,Urea cycle and metabolism of amino groups WP497,0.6598010621901383,0.9674602445077672,0.4022863297306986,['SRM'],0.9991254480717237,0,0,1
286,ATM Signaling Network in Development and Disease  WP3878,0.6628563565849204,0.8865248226950354,0.36453632003935765,"['HSPB1', 'HMGN1', 'CDK5R1']",0.9991254480717237,0,0,3
287,IL-4 signaling pathway WP395,0.6628563565849204,0.8865248226950354,0.36453632003935765,"['CEBPB', 'HRH1', 'NFIL3']",0.9991254480717237,0,0,3
288,Alpha 6 Beta 4 signaling pathway WP244,0.6669949538758261,0.8866396761133604,0.35906495089559987,"['PRKCD', 'GAB1']",0.9991254480717237,0,0,2
289,Nucleotide Excision Repair WP4753,0.6798076856934725,0.8624825433336072,0.3328711149537614,"['RPA3', 'POLE2', 'POLE3']",0.9991254480717237,0,0,3
290,Corticotropin-releasing hormone signaling pathway WP2355,0.6800503711626117,0.8716817841391362,0.33611039170450896,"['CRHBP', 'HSP90AA1', 'TGFB1', 'PRKCD', 'CRH']",0.9991254480717237,0,0,5
291,Glycolysis and Gluconeogenesis WP534,0.6873295513668128,0.8510931174089069,0.3191100496225439,"['PGAM1', 'ALDOC']",0.9991254480717237,0,0,2
292,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.6873295513668128,0.8510931174089069,0.3191100496225439,"['PRKCH', 'PRKCD']",0.9991254480717237,0,0,2
293,miRNA regulation of prostate cancer signaling pathways WP3981,0.6873295513668128,0.8510931174089069,0.3191100496225439,"['CDKN1B', 'TCF7']",0.9991254480717237,0,0,2
294,Prion disease pathway WP3995,0.6873295513668128,0.8510931174089069,0.3191100496225439,"['PRNP', 'HSPA5']",0.9991254480717237,0,0,2
295,Globo Sphingolipid Metabolism WP1424,0.6890520331529129,0.8867542972699697,0.33026143236690153,['B3GALNT1'],0.9991254480717237,0,0,1
296,Kallmann's Syndrome WP5074,0.6890520331529129,0.8867542972699697,0.33026143236690153,['ASCL1'],0.9991254480717237,0,0,1
297,NAD+ metabolism WP3644,0.6890520331529129,0.8867542972699697,0.33026143236690153,['NMNAT1'],0.9991254480717237,0,0,1
298,Nicotine Activity on Dopaminergic Neurons WP1602,0.6890520331529129,0.8867542972699697,0.33026143236690153,['CHRNA6'],0.9991254480717237,0,0,1
299,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.6890520331529129,0.8867542972699697,0.33026143236690153,['ASCL1'],0.9991254480717237,0,0,1
300,Omega-9 FA synthesis WP4724,0.6890520331529129,0.8867542972699697,0.33026143236690153,['ACOT2'],0.9991254480717237,0,0,1
301,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.6961178840055545,0.8397056470964646,0.30417183261690023,"['ADCY10', 'TGFB1', 'BANF1']",0.9992823696951507,0,0,3
302,Purinergic signaling WP4900,0.7157902575744541,0.8184646496072179,0.27366846267279976,['P2RY14'],0.9992823696951507,0,0,1
303,Transcription factor regulation in adipogenesis WP3599,0.7157902575744541,0.8184646496072179,0.27366846267279976,['CEBPB'],0.9992823696951507,0,0,1
304,Triacylglyceride synthesis WP325,0.7157902575744541,0.8184646496072179,0.27366846267279976,['AGPAT1'],0.9992823696951507,0,0,1
305,Head and Neck Squamous Cell Carcinoma WP4674,0.7202057281454672,0.8179123108129194,0.2684538489346636,"['CDKN2A', 'GAB1', 'FAT1', 'FGFR2']",0.9992823696951507,0,0,4
306,Hedgehog Signaling Pathway WP4249,0.7249290858276461,0.7878992352676564,0.2534525618072489,"['HHIP', 'GLI3']",0.9992823696951507,0,0,2
307,Type 2 papillary renal cell carcinoma WP4241,0.7249290858276461,0.7878992352676564,0.2534525618072489,"['TGFB1', 'COL21A1']",0.9992823696951507,0,0,2
308,DNA IR-double strand breaks and cellular response via ATM WP3959,0.7268332887793851,0.7975683890577507,0.2544706880644236,"['CDKN2A', 'ACTL6A', 'BAX']",0.9992823696951507,0,0,3
309,Calcium Regulation in the Cardiac Cell WP536,0.7294171032970603,0.8416849831622674,0.2655596523293906,"['GJD2', 'RGS2', 'PRKCH', 'RGS16', 'CHRM5', 'PRKCD', 'ADRA1D', 'CALR']",0.9992823696951507,0,0,8
310,Endoderm differentiation WP2853,0.7382394092855108,0.8265174635469651,0.2508373915520072,"['DUSP4', 'SFRP1', 'TGFB1', 'TCF7', 'SLC2A12', 'PBX3', 'PTHLH']",0.9992823696951507,0,0,7
311,Ebstein-Barr virus LMP1 signaling WP262,0.7402313881244427,0.7599306658962878,0.22858141062894904,['HSP90AA1'],0.9992823696951507,0,0,1
312,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.7402313881244427,0.7599306658962878,0.22858141062894904,['MYLK'],0.9992823696951507,0,0,1
313,Mitochondrial complex III assembly WP4921,0.7402313881244427,0.7599306658962878,0.22858141062894904,['UQCC3'],0.9992823696951507,0,0,1
314,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.7402313881244427,0.7599306658962878,0.22858141062894904,['SRXN1'],0.9992823696951507,0,0,1
315,Toll-like Receptor Signaling related to MyD88 WP3858,0.7402313881244427,0.7599306658962878,0.22858141062894904,['TIRAP'],0.9992823696951507,0,0,1
316,Copper homeostasis WP3286,0.7422512173002492,0.7596876807403123,0.22643822701876465,"['PRNP', 'COX17']",0.9992823696951507,0,0,2
317,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.7422512173002492,0.7596876807403123,0.22643822701876465,"['IFITM3', 'DDIT3']",0.9992823696951507,0,0,2
318,TGF-beta Signaling Pathway WP366,0.7478855113421213,0.8173566006729791,0.23744648368297547,"['TGFBR3', 'TGFB1', 'FN1', 'STRAP', 'NEDD9', 'ETS1', 'RUNX2']",0.9992823696951507,0,0,7
319,AGE/RAGE pathway WP2324,0.7550615739573944,0.7594442032132002,0.21337038896265173,"['PRKCD', 'CYCS', 'TIRAP']",0.9992823696951507,0,0,3
320,Alzheimer's disease WP2059,0.7576844442561872,0.7730776323068412,0.2145199828589804,"['PSEN2', 'CYCS', 'APOE', 'CDK5R1']",0.9992823696951507,0,0,4
321,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.7586306119007034,0.73342175066313,0.20260064251550486,"['IGFBP5', 'PLD1']",0.9992823696951507,0,0,2
322,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.7586306119007034,0.73342175066313,0.20260064251550486,"['TGFB1', 'IFIT2']",0.9992823696951507,0,0,2
323,Signaling of Hepatocyte Growth Factor Receptor WP313,0.7586306119007034,0.73342175066313,0.20260064251550486,"['GAB1', 'PTK2B']",0.9992823696951507,0,0,2
324,Immune response to tuberculosis WP4197,0.7625725866010604,0.709201213346815,0.19223436426045248,['IFIT3'],0.9992823696951507,0,0,1
325,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.7625725866010604,0.709201213346815,0.19223436426045248,['CEBPB'],0.9992823696951507,0,0,1
326,Monoamine Transport WP727,0.7625725866010604,0.709201213346815,0.19223436426045248,['AGT'],0.9992823696951507,0,0,1
327,"Relationship between inflammation, COX-2 and EGFR WP4483",0.7625725866010604,0.709201213346815,0.19223436426045248,['PTGES2'],0.9992823696951507,0,0,1
328,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.7682697215763976,0.7417120237506185,0.19552597569257055,"['CDKN1B', 'FN1', 'MYLK']",0.9992823696951507,0,0,3
329,7-oxo-C and 7beta-HC pathways WP5064,0.7829941076948799,0.6648129423660263,0.16263326209924728,['ACOT2'],0.9992823696951507,0,0,1
330,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.7829941076948799,0.6648129423660263,0.16263326209924728,['H3F3B'],0.9992823696951507,0,0,1
331,Purine metabolism and related disorders WP4224,0.7829941076948799,0.6648129423660263,0.16263326209924728,['PRPS1'],0.9992823696951507,0,0,1
332,TLR4 Signaling and Tolerance WP3851,0.7829941076948799,0.6648129423660263,0.16263326209924728,['TIRAP'],0.9992823696951507,0,0,1
333,Hepatitis B infection WP4666,0.7839309462398178,0.7826417518873481,0.19052187933411452,"['TGFB1', 'ATP6AP1', 'VDAC3', 'CYCS', 'PTK2B', 'BAX', 'TIRAP']",0.9992823696951507,0,0,7
334,DNA IR-damage and cellular response via ATR WP4016,0.7911572981502702,0.732881023991047,0.17168358819535326,"['SEM1', 'BRIP1', 'POLN', 'ABRAXAS1']",0.9992823696951507,0,0,4
335,3q29 copy number variation syndrome WP4906,0.7929398570669391,0.7086119554204661,0.1644035734704647,"['TGFB1', 'NCBP2', 'WDR34']",0.9992823696951507,0,0,3
336,Rett syndrome causing genes WP4312,0.7929398570669391,0.7086119554204661,0.1644035734704647,"['KCNJ10', 'SATB2', 'GABRD']",0.9992823696951507,0,0,3
337,16p11.2 distal deletion syndrome WP4950,0.8016607477766352,0.6256468209123892,0.1383115977795589,['CD81'],0.9992823696951507,0,0,1
338,1q21.1 copy number variation syndrome WP4905,0.8016607477766352,0.6256468209123892,0.1383115977795589,['FMO5'],0.9992823696951507,0,0,1
339,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.8016607477766352,0.6256468209123892,0.1383115977795589,['SGK1'],0.9992823696951507,0,0,1
340,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.8016607477766352,0.6256468209123892,0.1383115977795589,['PDHB'],0.9992823696951507,0,0,1
341,Trans-sulfuration and one-carbon metabolism WP2525,0.8016607477766352,0.6256468209123892,0.1383115977795589,['AHCY'],0.9992823696951507,0,0,1
342,Tryptophan metabolism WP465,0.8016607477766352,0.6256468209123892,0.1383115977795589,['ACMSD'],0.9992823696951507,0,0,1
343,Vitamin D in inflammatory diseases WP4482,0.8016607477766352,0.6256468209123892,0.1383115977795589,['DUSP1'],0.9992823696951507,0,0,1
344,Wnt signaling in kidney disease WP4150,0.8016607477766352,0.6256468209123892,0.1383115977795589,['WNT5B'],0.9992823696951507,0,0,1
345,Insulin Signaling WP481,0.8101915281770209,0.7766838218840904,0.16347998724719776,"['XBP1', 'RPS6KA5', 'PRKCH', 'SHC3', 'PRKCD', 'GAB1', 'SGK1', 'GYG1', 'ARF6']",0.9992823696951507,0,0,9
346,Oxidative phosphorylation WP623,0.8153816393311148,0.6783289141822415,0.13844625727971055,"['NDUFA7', 'ATP6AP1', 'ATP6AP2']",0.9992823696951507,0,0,3
347,Gastric Cancer Network 2 WP2363,0.8187231692884774,0.5908324907313784,0.11817197097110564,['DSCC1'],0.9992823696951507,0,0,1
348,Metabolic reprogramming in colon cancer WP4290,0.8276060333280902,0.6252679209335557,0.11831197234183664,"['PGAM1', 'PDHB']",0.9992823696951507,0,0,2
349,B Cell Receptor Signaling Pathway WP23,0.8299004540564764,0.6853366485637636,0.12778068933854836,"['CD81', 'PRKCD', 'GAB1', 'ETS1']",0.9992823696951507,0,0,4
350,PI3K-Akt signaling pathway WP4172,0.8303974281724924,0.7877935370668226,0.14641210925758533,"['HSP90AA1', 'CDKN1B', 'ANGPT2', 'F2R', 'FN1', 'PPP2R5B', 'FGF1', 'EFNA3', 'RELN', 'IL7', 'COL6A6', 'SGK1', 'FGFR2']",0.9992823696951507,0,0,13
351,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.8343191117898803,0.559682826885211,0.10138056766349769,['PTHLH'],0.9992823696951507,0,0,1
352,Glycosylation and related congenital defects WP4521,0.8343191117898803,0.559682826885211,0.10138056766349769,['MAGT1'],0.9992823696951507,0,0,1
353,Sphingolipid Metabolism (general overview) WP4725,0.8343191117898803,0.559682826885211,0.10138056766349769,['CERS4'],0.9992823696951507,0,0,1
354,Male infertility WP4673,0.8385961355693979,0.6743938954892301,0.11871089521869665,"['ABCB1', 'PEX10', 'TEX15', 'ETV5']",0.9992823696951507,0,0,4
355,MAPK Signaling Pathway WP382,0.8473495457725081,0.7665015891788011,0.1269648428971824,"['DUSP4', 'RPS6KA5', 'TGFB1', 'GADD45A', 'DUSP1', 'DDIT3', 'PRKCD', 'HSPB1', 'FGF1', 'HSPA1B', 'FGFR2', 'DUSP7']",0.9992823696951507,0,0,12
356,Sphingolipid Metabolism (integrated pathway) WP4726,0.848574499144339,0.5316481294236602,0.08729523906009155,['CERS4'],0.9992823696951507,0,0,1
357,Regulation of Actin Cytoskeleton WP51,0.8507172753047482,0.714296893340637,0.11548425883717316,"['CHRM5', 'F2R', 'FN1', 'FGF1', 'FGFR2', 'MYLK', 'ACTG1']",0.9992823696951507,0,0,7
358,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.8548711049428351,0.6535184896239663,0.10247468958398105,"['SHC3', 'GAB1', 'BAX', 'FGFR2']",0.9992823696951507,0,0,4
359,Histone Modifications WP2369,0.859941423427254,0.5744063901958639,0.08667275712069059,"['SET', 'H3F3B']",0.9992823696951507,0,0,2
360,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.8626043520473915,0.6128127191956979,0.09057319870850547,"['CDKN1B', 'APEX1', 'PLD1']",0.9992823696951507,0,0,3
361,Regulation of Microtubule Cytoskeleton WP2038,0.8694221231767134,0.5592371617302365,0.07825210668732867,"['SPRED1', 'TESK2']",0.9992823696951507,0,0,2
362,Ciliopathies WP4803,0.8754275562428788,0.7121730795563467,0.09474955490049025,"['MAK', 'NME9', 'CCDC65', 'DNAAF4', 'CCNQ', 'WDR34', 'TRIM32', 'CCDC28B', 'GLI3']",0.9992823696951507,0,0,9
363,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.8844000043037041,0.4621708357145997,0.05677575766558524,['AGT'],0.9992823696951507,0,0,1
364,Signal transduction through IL1R WP4496,0.8844000043037041,0.4621708357145997,0.05677575766558524,['TGFB1'],0.9992823696951507,0,0,1
365,Circadian rhythm related genes WP3594,0.8895474121189848,0.6840549241179948,0.08006347882918138,"['PER2', 'HTR7', 'AHCY', 'NFIL3', 'CRH', 'ATF5', 'HCRTR2', 'CIART']",0.9992823696951507,0,0,8
366,Glycerophospholipid Biosynthetic Pathway WP2533,0.8943497739961019,0.44287158746208294,0.049450303740349824,['CDIPT'],0.9992823696951507,0,0,1
367,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.8943497739961019,0.44287158746208294,0.049450303740349824,['CDKN1B'],0.9992823696951507,0,0,1
368,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.8966963981540941,0.7181033586357491,0.07830050936108188,"['EFNA3', 'HSP90AA1', 'CDKN1B', 'RELN', 'ANGPT2', 'COL5A3', 'F2R', 'COL5A2', 'FN1', 'PPP2R5B', 'FGF1', 'FGFR2']",0.9992823696951507,0,0,12
369,Focal Adhesion WP306,0.898665093733369,0.6730675977111822,0.07191380376869003,"['RELN', 'SHC3', 'COL5A3', 'COL5A2', 'FN1', 'TESK2', 'MYLK', 'ACTG1']",0.9992823696951507,0,0,8
370,16p11.2 proximal deletion syndrome WP4949,0.8988690191547812,0.5587905935050392,0.059577108275337375,"['IGFBP3', 'KCTD13', 'CDIPT']",0.9992823696951507,0,0,3
371,Cardiac Hypertrophic Response WP2795,0.9017247324775204,0.5057836899942163,0.052321289546061515,"['TGFB1', 'FGFR2']",0.9992823696951507,0,0,2
372,Notch Signaling Pathway Netpath WP61,0.9017247324775204,0.5057836899942163,0.052321289546061515,"['MAML2', 'PSEN2']",0.9992823696951507,0,0,2
373,Intraflagellar transport proteins binding to dynein WP4532,0.9034439347238991,0.42511627906976746,0.04316682744982174,['WDR34'],0.9992823696951507,0,0,1
374,Nanoparticle-mediated activation of receptor signaling WP2643,0.9034439347238991,0.42511627906976746,0.04316682744982174,['FN1'],0.9992823696951507,0,0,1
375,Androgen receptor signaling pathway WP138,0.9066889102043917,0.5814554447192197,0.056956977063025514,"['CALR', 'FKBP4', 'ETV5', 'RUNX2']",0.9992823696951507,0,0,4
376,G Protein Signaling Pathways WP35,0.9066889102043917,0.5814554447192197,0.056956977063025514,"['GNA14', 'PRKCH', 'PRKD3', 'PRKCD']",0.9992823696951507,0,0,4
377,Neural Crest Cell Migration during Development WP4564,0.9117559945517083,0.40872676363070704,0.03775935332535008,['EPHB3'],0.9992823696951507,0,0,1
378,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9127394948721695,0.6396674500999755,0.058404688018661596,"['LINGO1', 'RAB3A', 'RPS6KA5', 'SHC3', 'PRKCD', 'PTK2B', 'CDK5R1']",0.9992823696951507,0,0,7
379,Translation Factors WP107,0.9149224347817313,0.48270150901729847,0.042919881597944236,"['EIF4A2', 'EEF1G']",0.9992823696951507,0,0,2
380,ATM Signaling Pathway WP2516,0.9193531519863888,0.39355128637231773,0.03309174098231863,['GADD45A'],0.9992823696951507,0,0,1
381,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.9193531519863888,0.39355128637231773,0.03309174098231863,['SUPT4H1'],0.9992823696951507,0,0,1
382,Hepatitis C and Hepatocellular Carcinoma WP3646,0.926296837263455,0.3794597717752419,0.029051643936490807,['TGFB1'],0.9992823696951507,0,0,1
383,IL-5 signaling pathway WP127,0.926296837263455,0.3794597717752419,0.029051643936490807,['SPRED1'],0.9992823696951507,0,0,1
384,Mitochondrial CIV Assembly WP4922,0.926296837263455,0.3794597717752419,0.029051643936490807,['COX17'],0.9992823696951507,0,0,1
385,Pathways affected in adenoid cystic carcinoma WP3651,0.9264419273328219,0.4616264742122866,0.03527006982377137,"['MYCBP', 'FOXP2']",0.9992823696951507,0,0,2
386,Mitochondrial complex I assembly model OXPHOS system WP4324,0.9316338421360456,0.4517615643035576,0.031991682537960656,"['NDUFA7', 'NDUFB11']",0.9992823696951507,0,0,2
387,Amyotrophic lateral sclerosis (ALS) WP2447,0.9326432069145077,0.36634008577106797,0.02554583426686008,['BAX'],0.9992823696951507,0,0,1
388,IL-2 signaling pathway WP49,0.9326432069145077,0.36634008577106797,0.02554583426686008,['PTK2B'],0.9992823696951507,0,0,1
389,Neural Crest Cell Migration in Cancer WP4565,0.9326432069145077,0.36634008577106797,0.02554583426686008,['EPHB3'],0.9992823696951507,0,0,1
390,TNF-alpha signaling pathway WP231,0.935190719416579,0.4973404255319149,0.03332419201884748,"['HSP90AA1', 'RFK', 'BAX']",0.9992823696951507,0,0,3
391,Regulatory circuits of the STAT3 signaling pathway WP4538,0.9364776616160327,0.4423076923076923,0.02902848153869209,"['F2R', 'IL6ST']",0.9992823696951507,0,0,2
392,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.9384435960569325,0.3540950455005056,0.022496552281355154,['ACTG1'],0.9992823696951507,0,0,1
393,Netrin-UNC5B signaling pathway WP4747,0.9384435960569325,0.3540950455005056,0.022496552281355154,['PTK2B'],0.9992823696951507,0,0,1
394,Notch Signaling WP268,0.9384435960569325,0.3540950455005056,0.022496552281355154,['PSEN2'],0.9992823696951507,0,0,1
395,Vitamin D-sensitive calcium signaling in depression WP4698,0.9384435960569325,0.3540950455005056,0.022496552281355154,['ATP2B4'],0.9992823696951507,0,0,1
396,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.9409948046877187,0.4332396926381889,0.026348624527478076,"['TCF7', 'ACTG1']",0.9992823696951507,0,0,2
397,DNA Repair Pathways Full Network WP4946,0.9419333742299615,0.5520304568527918,0.03302286761655172,"['BRIP1', 'RPA3', 'POLE2', 'APEX1', 'POLE3']",0.9992823696951507,0,0,5
398,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.9437449319683728,0.342640007828044,0.019838633234605992,['GABRD'],0.9992823696951507,0,0,1
399,NO/cGMP/PKG mediated Neuroprotection WP4008,0.9437449319683728,0.342640007828044,0.019838633234605992,['CYCS'],0.9992823696951507,0,0,1
400,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.9447864972069666,0.5171919061989808,0.02937458971125005,"['NDUFA7', 'COX17', 'SLC25A5', 'COX7A1']",0.9992823696951507,0,0,4
401,Gastrin signaling pathway WP4659,0.9447864972069666,0.5171919061989808,0.02937458971125005,"['PRKCH', 'CDKN1B', 'CDKN2A', 'PRKCD']",0.9992823696951507,0,0,4
402,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9479977170622843,0.5109118013636696,0.027284317391811714,"['TGFB1', 'WNT5B', 'FN1', 'STRAP']",0.9992823696951507,0,0,4
403,G13 Signaling Pathway WP524,0.9485901122595537,0.33190091001011124,0.017517228561839324,['IQGAP2'],0.9992823696951507,0,0,1
404,IL-3 signaling pathway WP286,0.9485901122595537,0.33190091001011124,0.017517228561839324,['TGFB1'],0.9992823696951507,0,0,1
405,EGF/EGFR signaling pathway WP437,0.9486858504571728,0.5836463982185339,0.030745072456391437,"['RPS6KA5', 'PRKCD', 'GAB1', 'PTK2B', 'SPRY2', 'PLD1', 'ARF6']",0.9992823696951507,0,0,7
406,Ras signaling WP4223,0.9486858504571728,0.5836463982185339,0.030745072456391437,"['HTR7', 'SHC3', 'GAB1', 'PLD1', 'ETS1', 'FGFR2', 'ARF6']",0.9992823696951507,0,0,7
407,MET in type 1 papillary renal cell carcinoma WP4205,0.9527839549852642,0.40812830893802554,0.019739983114376865,"['GAB1', 'ETS1']",0.9992823696951507,0,0,2
408,22q11.2 copy number variation syndrome WP4657,0.9533010010843698,0.4610810096471521,0.022051005336308653,"['RELN', 'DGCR6L', 'FGFR2']",0.9992823696951507,0,0,3
409,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.9607643057424862,0.30336559295103277,0.012142559599927298,['LCP2'],0.9992823696951507,0,0,1
410,Common Pathways Underlying Drug Addiction WP2636,0.9641447413814502,0.2949106841927873,0.010768324185563045,['ACTG1'],0.9992823696951507,0,0,1
411,ErbB signaling pathway WP673,0.9642587698338162,0.4356497480950993,0.01585572828908141,"['CDKN1B', 'SHC3', 'GAB1']",0.9992823696951507,0,0,3
412,Hippo-Merlin Signaling Dysregulation WP4541,0.9665926663668908,0.42972151482789783,0.014601123456405777,"['PPP1R14A', 'FGFR2', 'CDH18']",0.9992823696951507,0,0,3
413,RANKL/RANK signaling pathway WP2018,0.9672341788606666,0.28691279752958215,0.009558397238392491,['PAPSS2'],0.9992823696951507,0,0,1
414,Splicing factor NOVA regulated synaptic proteins WP4148,0.9672341788606666,0.28691279752958215,0.009558397238392491,['NTNG1'],0.9992823696951507,0,0,1
415,Fragile X Syndrome  WP4549,0.9706736903651911,0.4901297236322617,0.014588673193131257,"['CDKN2A', 'GAD1', 'GAB1', 'PPP2R5B', 'GABRD']",0.9992823696951507,0,0,5
416,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.9726380156371892,0.27214746830520337,0.007550267541871302,['GTPBP2'],0.9992823696951507,0,0,1
417,Chemokine signaling pathway WP3929,0.9735991564413421,0.45064951879504556,0.012057399951254613,"['SHC3', 'PRKCD', 'PTK2B', 'CXCL14']",0.9992823696951507,0,0,4
418,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.9749962018491292,0.2653185035389282,0.006718316487962925,['RPS6KA5'],0.9992823696951507,0,0,1
419,Integrated breast cancer pathway WP1984,0.9754240582177967,0.4767457813143092,0.01186285146709664,"['GADD45A', 'BAX', 'HMGCR', 'JAKMIP1', 'BACH1']",0.9992823696951507,0,0,5
420,Wnt Signaling Pathway WP363,0.9791208320224921,0.25263614040156,0.005330678178504612,['ROR2'],0.9992823696951507,0,0,1
421,Leptin signaling pathway WP2034,0.9795133135582179,0.3365143628301523,0.006965662056611459,"['LEPR', 'BAX']",0.9992823696951507,0,0,2
422,Pathways in clear cell renal cell carcinoma WP4018,0.9795133135582179,0.3365143628301523,0.006965662056611459,"['TGFB1', 'ALDOC']",0.9992823696951507,0,0,2
423,Interferon type I signaling pathways WP585,0.9809207157734106,0.24673736684929573,0.004753060422851216,['RPS6KA5'],0.9992823696951507,0,0,1
424,Thermogenesis WP4321,0.9820068152696659,0.3827956201706522,0.006950431734861685,"['ADCY10', 'ACTL6A', 'ACTG1']",0.9992823696951507,0,0,3
425,Ciliary landscape WP4352,0.9833104391033697,0.5338624884032575,0.008985119681369148,"['PSMD8', 'DOCK5', 'GID8', 'VPS4A', 'HTRA2', 'COPS7A', 'VIM', 'IQGAP2', 'WDR34']",0.9992823696951507,0,0,9
426,Toll-like Receptor Signaling Pathway WP75,0.9888931097380151,0.2164008171519366,0.002416987723622317,['TIRAP'],0.9992823696951507,0,0,1
427,mRNA Processing WP411,0.9949059401789202,0.35512298225578265,0.0018136410453773045,"['PRPF4', 'NCBP2', 'SRSF9', 'LSM2']",0.9992823696951507,0,0,4
428,Amino Acid metabolism WP3925,0.9962382698129298,0.17363125528352866,0.0006543855184161726,['SRM'],0.9992823696951507,0,0,1
429,Mesodermal commitment pathway WP2857,0.9973696512581735,0.2376154301050812,0.000625834890931922,"['SLC2A12', 'PBX3']",0.9992823696951507,0,0,2
430,Joubert Syndrome WP4656,0.9973781435803972,0.1628840320448005,0.0004276193686418122,['PDE6B'],0.9992823696951507,0,0,1
431,Genes related to primary cilium development (based on CRISPR) WP4536,0.9979350170634586,0.22980109135715543,0.00047502596167695396,"['CDK20', 'WDR34']",0.9992823696951507,0,0,2
432,Regulation of toll-like receptor signaling pathway WP1449,0.9981725857913808,0.15338286367433068,0.0002805504435154613,['TIRAP'],0.9992823696951507,0,0,1
433,Integrin-mediated Cell Adhesion WP185,0.9987261995498049,0.14492291923487124,0.00018472055331967494,['SHC3'],0.9992823696951507,0,0,1
434,7q11.23 copy number variation syndrome WP4932,0.999111934575544,0.13734193006184917,0.00012202280955816655,['UBE2L6'],0.9992823696951507,0,0,1
435,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9992823696951507,0.2010989010989011,0.0001443664727762649,"['RPS6KA5', 'SHC3']",0.9992823696951507,0,0,2
